ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value. Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.
| Coronary Computed Tomographic Angiography |
|
Coronary computed tomographic angiography (CCTA) involves the use of CT scans in conjunction with the rapid injection of contrast material into a small peripheral vein to develop computer-aided, 3-dimensional images of the arterial anatomy of the heart. While CCTA can be used to define coronary artery anomalies and to generate “calcium scores” as a predictor of cardiac risk, its most significant application is as a minimally invasive method to diagnose coronary artery disease (CAD), the leading cause of death among both men and women in the U.S. Stakeholder groups invited to participate:
Clinical Organizations
Patient Advocacy Organizations
CCTA Evidence Review Group Key Questions CCTA Evidence Review Group Scoping Call Summary
Systematic Review of CCTA: Preliminary Findings Economic Model of CCTA for Detection of Coronary Artery Disease Draft Appraisal Document: CCTA For Detection of Coronary Artery Disease
Final Appraisal Documents CCTA Final Appraisal - Full Report CCTA Final Appraisal - Executive Summary CCTA Final Appraisal - Appendix A
Powered by !JoomlaComment 3.26
3.26 Copyright (C) 2008 Compojoom.com / Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved." |